SANWAY GENE Trademark

Trademark Overview


On Friday, January 5, 2024, a trademark application was filed for SANWAY GENE with the United States Patent and Trademark Office. The USPTO has given the SANWAY GENE trademark a serial number of 79398160. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, December 3, 2024. This trademark is owned by Sanway Gene Tech. Inc.. The SANWAY GENE trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; antibiotics; vaccine preparations; pharmaceutical preparations for treating allergies; preparations for detecting genetic predispositions for medical purposes; diagnostic preparations for medical purposes; diagnostic reagents for medical use; genetic identity tests comprised of reagents for medical purposes; reagent paper for medical purposes; reagents for medical use; biological preparations for medical purposes for the prevention and treatment of disorders of the digestive system, blood system, the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and of the genitourinary system, for the prevention and treatment of infectious diseases, viral diseases, and inflammatory disorders, for use in dermatology, oncology, hematology, tissue and organ transplantation, and ophthalmology and for the treatment of...

Surgical apparatus and instruments; apparatus for use in medical analysis, namely, apparatus for blood analysis, body composition analyzers, apparatus for analyzing and detecting bacteria and viruses, apparatus for analyzing and detecting DNA and RNA, apparatus for analyzing and detecting genes, apparatus for analyzing blood vessels, apparatus for immunoassay analysis, apparatus for organ and tissue cavitation detecting, and apparatus for medical imaging analysis; diagnostic apparatus for medical purposes in the nature of medical diagnostic imaging apparatus, for use with computer displays and computer monitors and for use with recorded computer operating software and recorded smartphone operating software, all sold as a unit; body composition analyzers for medical purposes; apparatus for DNA and RNA testing for medical purposes; analysers for bacterial identification for medical purposes; apparatus used in implementing diagnosis tests designed to detect the abnormal prion protein; gen...

General Information


Serial Number79398160
Word MarkSANWAY GENE
Filing DateFriday, January 5, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, December 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 3, 2024

Trademark Statements


Description of MarkThe mark consists of a stylized DNA double-helix inside a square background, and to the right of the design is the stylized word "SANWAY" and "GENE" with four Chinese characters arranged in two lines.
NOT AVAILABLEThe non-Latin characters in the mark transliterate to "Sheng Wei Ji Yin"  and this means "holy dimension gene" in English.
Goods and ServicesIntravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; antibiotics; vaccine preparations; pharmaceutical preparations for treating allergies; preparations for detecting genetic predispositions for medical purposes; diagnostic preparations for medical purposes; diagnostic reagents for medical use; genetic identity tests comprised of reagents for medical purposes; reagent paper for medical purposes; reagents for medical use; biological preparations for medical purposes for the prevention and treatment of disorders of the digestive system, blood system, the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and of the genitourinary system, for the prevention and treatment of infectious diseases, viral diseases, and inflammatory disorders, for use in dermatology, oncology, hematology, tissue and organ transplantation, and ophthalmology and for the treatment of gastroenterological disorders; diagnostic biomarker reagents for medical purposes; immunoassay reagents for medical use; enzyme preparations for medical purposes; reagents for use in medical genetic testing; mineral, vitamin, or nutritionally enhanced water for medical purposes; medicated water for the treatment of illnesses attributed to insufficient cellular energy; medicated water for the treatment of allergies, cough, cold, flu, headache, and pain; medicated water for the treatment of infectious diseases, skin diseases and conditions, and internal tissue diseases and conditions; medicated water for the treatment of pain, nausea and muscle spasms; medicated water-based solutions for treating skin infections and skin conditions; medicated water for the treatment of gastrointestinal disorders; demineralised water for medical purposes; diagnostic kits comprised of medical diagnostic reagents for use in disease testing, health monitoring, and predictive and preventive medicine in the fields of detecting diseases related to cancer, infectious diseases, viral diseases, hereditary diseases, inflammatory disorders, and oncological disorders of the digestive system, blood system, reproductive system, the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; purified biochemical medical diagnostic reagents, namely, protein arrays, enzymes, and fluorescent dyes for use as reagents in medical diagnostic applications; biological preparations for the diagnosis of disorders of the digestive system, blood system, the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system and for the diagnosis of cancer, hereditary diseases, infectious diseases, viral diseases, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; biological preparations for the treatment of disorders of the digestive system, blood system, the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system and for the treatment of cancer, hereditary diseases, infectious diseases, viral diseases, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; biochemical drugs for the diagnosis of disorders of the digestive system, blood system, the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system and for the diagnosis of cancer, infectious diseases, viral diseases, hereditary diseases, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; biochemical drugs for the treatment of disorders of the digestive system, blood system, the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system and for the treatment of cancer, infectious diseases, viral diseases, hereditary diseases, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; antibiotic tablets; allergy tablets; chemico-pharmaceutical preparations in the nature of biological indicators, in-vivo diagnostic agents, and in-vitro diagnostic reagents all for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, hereditary diseases, viral diseases, and diseases related to the digestive system, blood system, the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; chemical preparations in the nature of biological indicators, in-vivo diagnostic agents, and in-vitro diagnostic reagents all for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, hereditary diseases, viral diseases, and diseases related to the digestive system, blood system, the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; antibiotic ointments; anti-inflammatory ointments; medicated ointments for treating dermatological conditions; ointments for pharmaceutical purposes, namely, anti-itch ointments, hemorrhoidal ointments
NOT AVAILABLE"GENE" and the non-Latin Characters that transliterate to "JI YIN"
Goods and ServicesSurgical apparatus and instruments; apparatus for use in medical analysis, namely, apparatus for blood analysis, body composition analyzers, apparatus for analyzing and detecting bacteria and viruses, apparatus for analyzing and detecting DNA and RNA, apparatus for analyzing and detecting genes, apparatus for analyzing blood vessels, apparatus for immunoassay analysis, apparatus for organ and tissue cavitation detecting, and apparatus for medical imaging analysis; diagnostic apparatus for medical purposes in the nature of medical diagnostic imaging apparatus, for use with computer displays and computer monitors and for use with recorded computer operating software and recorded smartphone operating software, all sold as a unit; body composition analyzers for medical purposes; apparatus for DNA and RNA testing for medical purposes; analysers for bacterial identification for medical purposes; apparatus used in implementing diagnosis tests designed to detect the abnormal prion protein; genetic testing apparatus for medical purposes; medical equipment, namely, devices for bioanalysis of pathogens in the nature of reagent cartridges for sample preparation, nucleic acid purification, nucleic acid amplification and electrochemical detection all for medical diagnostic purposes; gene testing medical apparatus for identification of genus specific and species specific DNA and RNA sequences; immunochemical testing apparatus for medical use; immunochemical medical diagnostic testing apparatus for detecting and measuring antibody levels; medical diagnostic apparatus for testing for viruses; medical diagnostic apparatus for testing DNA and RNA samples

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 28, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, June 28, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSanway Gene Tech. Inc.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCN

Party NameSanway Gene Tech. Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Thursday, June 20, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, June 28, 2024LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, July 2, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 2, 2024APPLICATION FILING RECEIPT MAILED
Thursday, August 1, 2024ASSIGNED TO EXAMINER
Wednesday, August 7, 2024NON-FINAL ACTION WRITTEN
Monday, August 19, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, September 9, 2024REFUSAL PROCESSED BY IB
Thursday, August 8, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, August 17, 2024REFUSAL PROCESSED BY MPU
Wednesday, October 16, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 16, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 5, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 27, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 3, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 3, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, October 17, 2024TEAS/EMAIL CORRESPONDENCE ENTERED